Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beta-Thalassemia
Drug may eliminate transfusions in patients with blood disorder
September 1st, 2003
The use of hydroxyurea may eliminate the need for future blood transfusions in children with beta-thalassemia major, an inherited blood disorder, according to a new study. Beta-thalassemia occurs when a person is unable to produce adequate levels of hemoglobin, the oxygen-carrying component of red blood cells. This genetic disorder probably arose about 6000 years ago as a partial defense against malaria. The most common treatment for severe forms of beta-thalassemia is red blood cell transfusions, which provide the patient with a temporary supply of healthy cells that function normally and supply the body with the needed oxygen. However, patients may...
Source: Health & Medicine Week (2003-09-01)
|
